Cenduit to Showcase Upgraded Tool at DIA 2016
Upgraded tool improves sponsor-patient communication with two-way messaging dashboard
Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world with the unveiling of its upgraded
Patient Reminders
tool at DIA 2016 from June 26-30 in Philadelphia, Pennsylvania. Cenduit Director of Product Management Kim Lanza-Russo will be representing Cenduit at the conference to discuss the company’s innovative IRT systems, as well as Cenduit’s upgraded Patient Reminders tool. Designed to improve patient compliance and engagement without placing additional burdens on sites or sponsors, the expanded features include a two-way messaging dashboard and a mobile app available for iOS and Android devices. “Our upgraded Patient Reminders tool gives sponsors more control of their clinical trials, which saves them time and money while also reducing patient dropout,” said Kim Lanza-Russo, director of product management, Cenduit. “Patient compliance is key to the success of any clinical trial. With our two-way messaging dashboard, sponsors can keep patients engaged throughout their trials by communicating in real time through the two-way messaging dashboard.” Attendees are invited to stop by the Cenduit booth, #1043, to experience the new Patient Reminders tool firsthand and to learn how the company’s IRT solutions can help sponsors increase efficiencies and reduce costs to get their product to market faster. Sunday, June 26 â Thursday, June 30, 2016 Pennsylvania Convention Center 1101 Arch Street Philadelphia, PA 19107 To schedule an appointment with Kim Lanza-Russo to discuss patient reminders, please contact Greyson Feurer at Largemouth Communications, (919) 459-6450, greyson@largemouthpr.com. Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, China, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at
www.cenduit.com
; on Twitter
@CenduitLLC
or on
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
